DE LUCA, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 735
AS - Asia 467
EU - Europa 346
AF - Africa 108
SA - Sud America 107
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 1.785
Nazione #
US - Stati Uniti d'America 672
SG - Singapore 177
HK - Hong Kong 87
CN - Cina 82
IT - Italia 82
BR - Brasile 57
DE - Germania 46
FI - Finlandia 25
NL - Olanda 22
GB - Regno Unito 21
PL - Polonia 17
CI - Costa d'Avorio 14
RU - Federazione Russa 14
FR - Francia 13
UY - Uruguay 10
EC - Ecuador 9
AR - Argentina 8
AU - Australia 8
KR - Corea 8
IN - India 7
VN - Vietnam 7
CA - Canada 6
DK - Danimarca 6
GH - Ghana 6
HN - Honduras 6
JO - Giordania 6
JP - Giappone 6
LA - Repubblica Popolare Democratica del Laos 6
ME - Montenegro 6
PY - Paraguay 6
TR - Turchia 6
AD - Andorra 5
AE - Emirati Arabi Uniti 5
AO - Angola 5
BF - Burkina Faso 5
CW - ???statistics.table.value.countryCode.CW??? 5
ES - Italia 5
GT - Guatemala 5
IQ - Iraq 5
KE - Kenya 5
LY - Libia 5
MD - Moldavia 5
NO - Norvegia 5
PA - Panama 5
PE - Perù 5
RO - Romania 5
SI - Slovenia 5
ZA - Sudafrica 5
AT - Austria 4
BA - Bosnia-Erzegovina 4
BS - Bahamas 4
CG - Congo 4
CM - Camerun 4
CU - Cuba 4
DZ - Algeria 4
GM - Gambi 4
IS - Islanda 4
LV - Lettonia 4
NC - Nuova Caledonia 4
NG - Nigeria 4
NP - Nepal 4
RS - Serbia 4
SA - Arabia Saudita 4
SE - Svezia 4
TJ - Tagikistan 4
TW - Taiwan 4
VE - Venezuela 4
YE - Yemen 4
YT - Mayotte 4
AF - Afghanistan, Repubblica islamica di 3
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
CH - Svizzera 3
CY - Cipro 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
HT - Haiti 3
ID - Indonesia 3
IE - Irlanda 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
MK - Macedonia 3
MN - Mongolia 3
MR - Mauritania 3
MW - Malawi 3
PH - Filippine 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
UA - Ucraina 3
UG - Uganda 3
VC - Saint Vincent e Grenadine 3
AZ - Azerbaigian 2
BG - Bulgaria 2
Totale 1.706
Città #
Ashburn 116
Singapore 104
Hong Kong 84
Woodbridge 48
Fairfield 47
Dallas 45
Santa Clara 34
Beijing 28
Munich 27
Seattle 27
Wilmington 23
Boardman 22
Cambridge 22
Ann Arbor 21
Houston 16
Chandler 15
Los Angeles 15
Abidjan 14
New York 14
Des Moines 13
Buffalo 12
Bytom 11
Helsinki 10
Montevideo 10
Council Bluffs 9
Hefei 9
Turku 9
London 7
Milan 7
Rome 7
Brisbane 6
Cagliari 6
Nuremberg 6
San Diego 6
Seoul 6
Amman 5
Andorra la Vella 5
Baghdad 5
Chisinau 5
Durham 5
Luanda 5
Medford 5
Nairobi 5
Padova 5
Portomaggiore 5
Princeton 5
Terrassa Padovana 5
Vientiane 5
Warsaw 5
Accra 4
Brooklyn 4
Dushanbe 4
Falkenstein 4
Havana 4
Nassau 4
Norwalk 4
Noumea 4
Oslo 4
Panama City 4
Podgorica 4
Quito 4
Redondo Beach 4
Riga 4
Roxbury 4
San Francisco 4
São Paulo 4
Willemstad 4
Banjul 3
Belgrade 3
Bologna 3
Bridgetown 3
Chicago 3
Cincinnati 3
Curitiba 3
Dubai 3
Guatemala City 3
Ho Chi Minh City 3
Hounslow 3
Kampala 3
Kingstown 3
Lainate 3
Ljubljana 3
Mamoudzou 3
Minsk 3
Newark 3
Nouakchott 3
Port-au-Prince 3
Reykjavik 3
Secaucus 3
Skopje 3
Stockholm 3
Tokyo 3
Tripoli 3
Ulan Bator 3
Villafranca Padovana 3
Winnipeg 3
Yerevan 3
Addis Ababa 2
Ankara 2
Antananarivo 2
Totale 1.094
Nome #
Moving beyond DTI: non-gaussian diffusion in the brain and skeletal muscle 214
Fractal analysis of MRI data for the characterization of patients with schizophrenia and bipolar disorder. 132
Effects of perfusion on DTI and DKI estimates in the skeletal muscle 126
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 123
Epilepsy in multiple sclerosis: The role of temporal lobe damage 110
Automatic localization of cerebral cortical malformations using fractal analysis 98
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 95
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: A longitudinal study 76
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 75
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 73
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 72
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 72
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 71
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 71
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 69
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region 63
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 61
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 57
Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program 56
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 50
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee 32
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2A 13
Totale 1.809
Categoria #
all - tutte 7.686
article - articoli 7.128
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.814


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 3 0 5 1 2 9 1 11 2
2021/202271 3 11 3 10 0 1 8 6 0 6 5 18
2022/202364 9 1 1 4 6 21 4 6 7 0 5 0
2023/2024167 1 33 10 13 14 11 23 12 11 12 15 12
2024/2025591 3 64 21 21 63 15 41 65 46 28 96 128
2025/2026703 155 115 433 0 0 0 0 0 0 0 0 0
Totale 1.809